BioCentury
ARTICLE | Company News

Matritech, Timm Medical Technologies Inc. sales and marketing update

January 22, 2001 8:00 AM UTC

Timm will exclusively distribute a point-of-care (POC) format of NMPS's NMP22 bladder cancer diagnostic to U.S. urologists. NMPS will receive an equity investment, marketing fees, milestone payments ...